OTTAWA, June 17, 2013 /CNW/ - Dr. Alain Beaudet, President of the
Canadian Institutes of Health Research (CIHR), along with CIHR's
Governing Council, announced today the appointment of Dr. Stephen
Robbins as incoming Scientific Director of CIHR's Institute of Cancer
Research. This appointment will be effective July 1, 2013.
"I'm pleased to welcome Dr. Robbins to the CIHR leadership team," said
Dr. Beaudet. "His excellent reputation in the field of oncology,
recognized leadership in translational research and commitment to
teaching excellence will be invaluable in advancing the work of the
Institute and of the CIHR Personalized Medicine Signature Initiative in
this next phase of their evolution."
Dr. Robbins is an Associate Professor in the Departments of Oncology and
Biochemistry and Molecular Biology at the University of Calgary, as
well as the Director of the Southern Alberta Cancer Research Institute,
one of seven Institutes within the Faculty of Medicine at the
University. He is currently a Scientist of the Alberta Heritage
Foundation for Medical Research (now called Alberta Innovates Health
Solutions) and the Associate Director Research for Alberta Health
Services Cancer Care, as well as former Canada Research Chair. He
joined the Faculty of Medicine at the University of Calgary in 1996
after training at the University of California, San Francisco in the
laboratory of Nobel laureate Dr. J. Michael Bishop.
His research activities include deciphering how extracellular signals
are recognized by cells to control cellular proliferation and
differentiation. During his research career, he favoured a more
translational approach, which led to defining new therapies for
malaria, the discovery of a novel class of anti-inflammatory agents and
new therapeutic targets for brain tumours. He has also developed and
fostered the use of the Microarray Technology to define molecular
blueprints of various childhood cancers.
"I am very honoured to be the new Scientific Director of the CIHR
Institute of Cancer Research and look forward to fostering and
promoting innovative research across all aspects of the cancer care
continuum from prevention to treatment to survivorship," said Dr.
Robbins. "I look forward to building on the previous outstanding
programs established by Drs. Phil Branton and Morag Park by working
with the entire cancer stakeholder community in Canada to develop
innovative research programs and platforms that have positive impact in
the lives of cancer patients and their families."
In addition to maintaining a productive research program, Dr. Robbins is
also committed to teaching. He has won several awards and distinctions
for outstanding teaching, including the 1999 and 2002 Watanabe Award
for Overall Excellence, as well as the 2003 McLeod Award for Excellence
in Teaching with the Faculty of Medicine at the University of Calgary.
Dr. Robbins' expertise is recognized nationally. He has served on and
chaired several national grant panels including the National Cancer
Institute of Canada, Cancer Research Society and the Canadian
Institutes of Health Research. He currently serves on the Advisory
Committee on Research for the Canadian Cancer Society Research
CIHR is comprised of 13 Institutes, each led by a Scientific Director,
responsible for championing health research at the highest levels of
international excellence, establishing and nurturing partnerships, as
well as fostering effective communication and knowledge dissemination.
CIHR's Institute of Cancer Research supports research that reduces the
burden of cancer on individuals and families through prevention
strategies, screening, diagnosis, effective treatment, psycho-social
support systems, and palliation. CIHR is one of the leading cancer
research funder in Canada.
The Canadian Institutes of Health Research (CIHR) is the Government of
Canada's health research investment agency. CIHR's mission is to create
new scientific knowledge and to enable its translation into improved
health, more effective health services and products, and a strengthened
health care system for Canadians. Composed of 13 Institutes, CIHR
provides leadership and support to more than 14,100 health researchers
and trainees across Canada.
SOURCE: Canadian Institutes of Health Research
For further information:
CIHR Media Relations
Phone: 613-941-4563, Cell: 613-808-7526